Pricing Log in Create free account

Ovid Therapeutics (OVID) vs ProKidney Corp. (PROK)

Ovid Therapeutics and ProKidney Corp. are both Biotechnology companies. Ovid Therapeutics and ProKidney Corp. are of similar size ($441.4M and $439.9M). Ovid Therapeutics has the higher net margin (−439.1% vs −10,288.4%) and the lower return on invested capital (−35.1% vs 0.00%). Across the 14 metrics below, Ovid Therapeutics leads on 11 and ProKidney Corp. on 3.

Valuation

Metric OVID PROK Biotechnology median
P/E n/m n/m 8.50
P/S 54.05 303.33 9.71
P/B 2.02 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 40.55 81.78 9.21
Earnings yield (10.48%) (41.35%) (33.15%)
Free cash flow yield (12.94%) (57.04%) (25.50%)

Profitability

Metric OVID PROK Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (742.97%) (21,664.55%) 0.00%
Net margin (439.11%) (10,288.39%) 0.00%
Free cash flow margin (697.30%) (17,300.61%) 0.00%
Return on equity (25.97%) 8.92% (56.36%)
Return on assets (22.30%) (27.10%) (48.04%)
Return on invested capital (35.11%) 0.00% 0.00%

Growth

Metric OVID PROK Biotechnology median
Revenue growth (TTM) 1,333.39% — 6.02%
EPS growth (last fiscal year) 37.84% 16.13% 30.26%
Revenue growth, 5-year CAGR (10.48%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OVID PROK Biotechnology median
Debt to equity 0.05 0.00 0.00
Current ratio 12.39 8.36 4.72
Net debt to EBITDA 1.37 1.70 0.96

Dividend

Metric OVID PROK Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric OVID PROK Biotechnology median
Market cap 441.37m 439.88m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack